57 related articles for article (PubMed ID: 37584254)
1. Dyslipidemic drugs in metabolic syndrome.
Siddiqi SS; Misbahuddin ; Ahmad F; Rahman SZ; Khan AU
Indian J Endocrinol Metab; 2013 May; 17(3):472-9. PubMed ID: 23869305
[TBL] [Abstract][Full Text] [Related]
2. Statins-From Fungi to Pharmacy.
Sadowska A; Osiński P; Roztocka A; Kaczmarz-Chojnacka K; Zapora E; Sawicka D; Car H
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203637
[TBL] [Abstract][Full Text] [Related]
3. Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease.
Curran MP
Drugs; 2010; 70(2):191-213. PubMed ID: 20108992
[TBL] [Abstract][Full Text] [Related]
4. A single-pill combination of amlodipine besylate and atorvastatin calcium.
Blank R
Drugs Today (Barc); 2006 Mar; 42(3):157-75. PubMed ID: 16628258
[TBL] [Abstract][Full Text] [Related]
5. Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia.
Jung HW; Kim CY; Hong SP; Bae HJ; Choi JY; Ryu JK; Lee JB; Lee KH; Han KR; Yang DH; Park CG; Yu GW; Rhee MY; Park SJ; Hyon MS; Shin JH; Hong BK; Jin HY; Lee SY; Seol SH; Lee SR; Kim SY; Lee KJ; Cho EJ; Nam CW; Park TH; Kim U; Kim KS
J Clin Hypertens (Greenwich); 2023 Sep; 25(9):828-844. PubMed ID: 37584254
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients with Dyslipidemia and Hypertension: A Multicenter Randomized Clinical Trial.
Park S; Hwang D; Kang J; Han JK; Yang HM; Park KW; Kang HJ; Koo BK; Cho JM; Cho BR; Ahn SG; Kang SM; Sung JH; Kim U; Lee N; Kim HS
Curr Ther Res Clin Exp; 2024; 100():100735. PubMed ID: 38380420
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial.
Hong SJ; Jeong HS; Cho JM; Chang K; Pyun WB; Ahn Y; Hyon MS; Kang WC; Lee JH; Kim HS
Clin Ther; 2019 Feb; 41(2):233-248.e9. PubMed ID: 30665829
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension.
Kim W; Chang K; Cho EJ; Ahn JC; Yu CW; Cho KI; Kim YJ; Kang DH; Kim SY; Lee SH; Kim U; Kim SJ; Ahn YK; Lee CH; Shin JH; Kim M; Park CG
J Clin Hypertens (Greenwich); 2020 Feb; 22(2):261-269. PubMed ID: 32003938
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind Study.
Kim TS; Rha SW; Kim SY; Park DG; Sung KC; Yoon MH; Kim KH; Lee HC; Kim WS; Kim YJ; Ahn JC; Rhee MY; Cha DH; Yoo BS; Park SH; Yoo KD; Jeon DW; Yoon YW; Cho SK; Oh YS
Clin Ther; 2019 Apr; 41(4):728-741. PubMed ID: 30904178
[TBL] [Abstract][Full Text] [Related]
10. Discovery Belux: comparison of rosuvastatin with atorvastatin in hypercholesterolaemia.
Herregods MC; Daubresse JC; Michel G; Lamotte M; Vissers E; Vandenhoven G;
Acta Cardiol; 2008 Aug; 63(4):493-9. PubMed ID: 18795588
[TBL] [Abstract][Full Text] [Related]
11. Statin's role on blood pressure levels: Meta-analysis based on randomized controlled trials.
Liu HT; Deng NH; Wu ZF; Zhou ZY; Tian Z; Liu XY; Wang YX; Zheng HY; Ou YS; Jiang ZS
J Clin Hypertens (Greenwich); 2023 Mar; 25(3):238-250. PubMed ID: 36799888
[TBL] [Abstract][Full Text] [Related]
12. Attitudes towards open-label versus placebo-control designs in oncology randomized trials: A survey of medical oncologists.
Kushnir I; Clemons M; Fergusson D; Bossé D; Reaume MN
J Eval Clin Pract; 2022 Jun; 28(3):495-499. PubMed ID: 35191169
[TBL] [Abstract][Full Text] [Related]
13. Hyperlipidemia and hypertension have synergistic interaction on ischemic stroke: insights from a general population survey in China.
Wang C; Du Z; Ye N; Shi C; Liu S; Geng D; Sun Y
BMC Cardiovasc Disord; 2022 Feb; 22(1):47. PubMed ID: 35152896
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target.
Behbodikhah J; Ahmed S; Elyasi A; Kasselman LJ; De Leon J; Glass AD; Reiss AB
Metabolites; 2021 Oct; 11(10):. PubMed ID: 34677405
[TBL] [Abstract][Full Text] [Related]
15. Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension: A Systematic Review and Meta-Analysis.
Parati G; Kjeldsen S; Coca A; Cushman WC; Wang J
Hypertension; 2021 Feb; 77(2):692-705. PubMed ID: 33390044
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
